Literature DB >> 32647420

Response to Horse ATG (Thymogam, Bharat Serums and Vaccine, India) and Cyclosporine in Aplastic Anemia: A Single Centre, Retrospective Study of 60 Patients from Southern India.

Deepak S Amalnath1.   

Abstract

Immunosuppressive therapy (IST), consisting of anti thymocyte globulin and cyclosporine, is the standard of care for elderly patients and in younger patients without matched donor for stem cell transplant. In this retrospective study of 60 patients, most had non severe AA (51.6%) followed by very severe AA (26.7%) and severe AA (21.7%). The response rate at 6 months was 68.3% (complete response-3.3% and partial response-65%). Of the 45 who completed 12 months follow up, RR was 54.7% (CR-7.5%, PR-47.2 %). Eight patients died during the study period. Also, Indian data on IST is briefly reviewed. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  ATG; Aplastic anemia; India; Thymogam

Year:  2019        PMID: 32647420      PMCID: PMC7326858          DOI: 10.1007/s12288-019-01137-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

1.  Guidelines for the diagnosis and management of adult aplastic anaemia.

Authors:  Sally B Killick; Nick Bown; Jamie Cavenagh; Inderjeet Dokal; Theodora Foukaneli; Anita Hill; Peter Hillmen; Robin Ireland; Austin Kulasekararaj; Ghulam Mufti; John A Snowden; Sujith Samarasinghe; Anna Wood; Judith C W Marsh
Journal:  Br J Haematol       Date:  2015-11-16       Impact factor: 6.998

2.  Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.

Authors:  Rajni Sharma; Jagdish Chandra; Sunita Sharma; Harish Pemde; Varinder Singh
Journal:  J Pediatr Hematol Oncol       Date:  2012-03       Impact factor: 1.289

Review 3.  Guidelines for the diagnosis and management of aplastic anaemia.

Authors:  Judith C W Marsh; Sarah E Ball; Jamie Cavenagh; Phil Darbyshire; Inderjeet Dokal; Edward C Gordon-Smith; Jane Keidan; Andrew Laurie; Anna Martin; Jane Mercieca; Sally B Killick; Rhona Stewart; John A L Yin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

4.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

Authors:  B M Camitta; E D Thomas; D G Nathan; G Santos; E C Gordon-Smith; R P Gale; J M Rappeport; R Storb
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

5.  Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.

Authors:  M B Agarwal; Farah Jijina; Sandip Shah; Pankaj Malhotra; Sharat Damodar; Cecil Ross
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-16       Impact factor: 0.900

6.  Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.

Authors:  Pankaj Malhotra; Vijay Bodh; Guru Subramanian Guru Murthy; Anup Kumar Datta; Neelam Varma; Subhash Varma
Journal:  Hematology       Date:  2014-09-02       Impact factor: 2.269

7.  Survival after immunosuppressive therapy in children with aplastic anemia.

Authors:  Velu Nair; Vishal Sondhi; Ajay Sharma; Satyaranjan Das; Sanjeevan Sharma
Journal:  Indian Pediatr       Date:  2011-10-30       Impact factor: 1.411

8.  Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.

Authors:  M Mahapatra; P K Singh; M Agarwal; M Prabhu; P Mishra; T Seth; S Tyagi; H P Patil; R Saxena
Journal:  J Assoc Physicians India       Date:  2015-03

9.  Immunosuppressive Therapy and Bone Marrow Transplantation for Aplastic Anaemia--The CMC Experience.

Authors:  Biju George; Vikram Mathews; Auro Viswabandya; Aby Abraham; Abhijeet Ganapule; N A Fouzia; Anu Korula; Kavitha N Lakshmi; Mammen Chandy; Alok Srivastava
Journal:  J Assoc Physicians India       Date:  2015-03

10.  Immunosuppressive therapy for aplastic anemia: a single-center experience from western India.

Authors:  Sandip Shah; Preetam Jain; Kamlesh Shah; Kinnari Patel; Sonia Parikh; Apurva Patel; Harsha Panchal; Asha Anand
Journal:  Ann Hematol       Date:  2018-09-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.